| Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial PB Gilbert, Y Fong, NS Hejazi, A Kenny, Y Huang, M Carone, D Benkeser, ... Vaccine, 2024 | | 2024 |
| Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine D Follmann, A Mateja, MP Fay, CA Magaret, Y Huang, Y Fong, H Angier, ... Clinical Infectious Diseases, ciae081, 2024 | 1 | 2024 |
| Package ‘FSDAM’ Y Fong, J Xu | | 2024 |
| A controlled effects approach to assessing immune correlates of protection PB Gilbert, Y Fong, A Kenny, M Carone Biostatistics 24 (4), 850-865, 2023 | 14 | 2023 |
| Stochastic interventional vaccine efficacy and principal surrogate analyses of antibody markers as correlates of protection against symptomatic COVID-19 in the COVE mRNA-1273 Trial Y Huang, NS Hejazi, B Blette, LN Carpp, D Benkeser, DC Montefiori, ... Viruses 15 (10), 2029, 2023 | 5 | 2023 |
| Optimizing Deep Learning-Based Segmentation of Densely Packed Cells using Cell Surface Markers S Han, K Phasouk, J Zhu, Y Fong Research Square, 2023 | | 2023 |
| Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration D Follmann, MP O’Brien, J Fintzi, MP Fay, D Montefiori, A Mateja, ... Nature Communications 14 (1), 3605, 2023 | 8 | 2023 |
| Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial D Benkeser, DC Montefiori, AB McDermott, Y Fong, HE Janes, W Deng, ... Science translational medicine 15 (692), eade9078, 2023 | 16 | 2023 |
| Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Y Fong, Y Huang, D Benkeser, LN Carpp, G Áñez, W Woo, A McGarry, ... nature communications 14 (1), 1581, 2023 | 1 | 2023 |
| Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine D Benkeser, Y Fong, HE Janes, EJ Kelly, I Hirsch, S Sproule, AM Stanley, ... npj Vaccines 8 (1), 36, 2023 | 14 | 2023 |
| Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection DS Khoury, TE Schlub, D Cromer, M Steain, Y Fong, PB Gilbert, ... Emerging Infectious Diseases 29 (2), 381, 2023 | 58 | 2023 |
| Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Y Fong, Y Huang, D Benkeser, LN Carpp, G Áñez, W Woo, A McGarry, ... Nature communications 14 (1), 331, 2023 | 49 | 2023 |
| Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial (preprint) B Zhang, Y Fong, J Fintzi, E Chu, HE Janes, LN Carpp, A Kenny, ... | | 2023 |
| Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial B Zhang, Y Fong, J Fintzi, E Chu, HE Janes, LN Carpp, A Kenny, ... medRxiv, 2023.10. 15.23295628, 2023 | | 2023 |
| Antibody correlates of protection from severe respiratory syncytial virus disease in a vaccine efficacy trial Y Fong, Y Huang, B Borate, LWP van der Laan, W Zhang, LN Carpp, ... Open Forum Infectious Diseases 10 (1), ofac693, 2023 | 3 | 2023 |
| Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape NI Mazur, J Terstappen, R Baral, A Bardají, P Beutels, UJ Buchholz, ... The Lancet Infectious Diseases 23 (1), e2-e21, 2023 | 181 | 2023 |
| A Covid-19 milestone attained—a correlate of protection for vaccines PB Gilbert, RO Donis, RA Koup, Y Fong, SA Plotkin, D Follmann New England Journal of Medicine 387 (24), 2203-2206, 2022 | 130 | 2022 |
| Fast estimation and choice of confidence interval methods for step regression S Hua, Y Fong, J Kath Environmental and Ecological Statistics 29 (4), 779-799, 2022 | | 2022 |
| Immune correlates analysis of the ENSEMBLE single Ad26. COV2. S dose vaccine efficacy clinical trial Y Fong, AB McDermott, D Benkeser, S Roels, DJ Stieh, A Vandebosch, ... Nature microbiology 7 (12), 1996-2010, 2022 | 56 | 2022 |
| Vapour pressure deficit determines critical thresholds for global coffee production under climate change J Kath, A Craparo, Y Fong, V Byrareddy, AP Davis, R King, T Nguyen-Huy, ... Nature Food 3 (10), 871-880, 2022 | 22 | 2022 |
| The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis R Luo, Y Fong, D Boeras, I Jani, L Vojnov The Lancet 400 (10356), 887-895, 2022 | 16 | 2022 |
| HIV viral load assays when used with whole blood perform well as a diagnostic assay for infants C Kiyaga, Y Fong, C Okiira, GE Kushemererwa, I Kayongo, I Tadeo, ... Plos one 17 (6), e0268127, 2022 | | 2022 |
| Testing a global null hypothesis using ensemble machine learning methods S Han, Y Fong, Y Huang Statistics in medicine 41 (13), 2417-2426, 2022 | | 2022 |
| Frequent development of broadly neutralizing antibodies in early life in a large cohort of children with human immunodeficiency virus A Lucier, Y Fong, SH Li, M Dennis, J Eudailey, A Nelson, K Saunders, ... The Journal of Infectious Diseases 225 (10), 1731-1740, 2022 | 7 | 2022 |
| Diagnostic accuracy of dried plasma spot specimens for HIV-1 viral load testing: a systematic review and meta-analysis Y Fong, J Markby, M Andreotti, I Beck, T Bourlet, D Brambilla, L Frenkel, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 89 (3), 261-273, 2022 | 4 | 2022 |
| Immune Assays Team § ; Moderna, Inc. Team § ; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team § ; United States Government (USG)/CoVPN … PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 64 | 2022 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 902 | 2022 |
| Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection (preprint) DS Khoury, TE Schlub, D Cromer, M Steain, Y Fong, PB Gilbert, ... | | 2022 |
| Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial (preprint) Y Fong, Y Huang, D Benkeser, LN Carpp, G Áñez, W Woo, A McGarry, ... | | 2022 |
| Immune Correlates Analysis of a Single Ad26. COV2. S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial (preprint) Y Fong, AB McDermott, D Benkeser, S Roels, DJ Stieh, A Vandebosch, ... | 1 | 2022 |
| Changepoint inference in the presence of missing covariates for principal surrogate evaluation in vaccine trials T Yang, Y Huang, Y Fong Biometrika 108 (4), 829-843, 2021 | 1 | 2021 |
| Improving random forest predictions in small datasets from two-phase sampling designs S Han, BD Williamson, Y Fong BMC medical informatics and decision making 21, 1-9, 2021 | 43 | 2021 |
| Forward Stepwise Deep Autoencoder-based Monotone Nonlinear Dimensionality Reduction Methods Y Fong, J Xu Journal of Computational and Graphical Statistics 30 (3), 519-529, 2021 | 6 | 2021 |
| Four-parameter paired response curve for serial dilution assays Y Fong, SR Permar, GD Tomaras Journal of biopharmaceutical statistics 31 (5), 634-649, 2021 | | 2021 |
| A deferred-vaccination design to assess durability of COVID-19 vaccine effect after the placebo group is vaccinated D Follmann, J Fintzi, MP Fay, HE Janes, LR Baden, HM El Sahly, ... Annals of internal medicine 174 (8), 1118-1125, 2021 | 17 | 2021 |
| Assessment of immune correlates of protection via controlled vaccine efficacy and controlled risk PB Gilbert, Y Fong, M Carone arXiv preprint arXiv:2107.05734, 2021 | 7 | 2021 |
| Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries Y Huang, Z Moodie, M Juraska, Y Fong, LN Carpp, L Chambonneau, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (7 …, 2021 | 4 | 2021 |
| Threshold models improve estimates of molt parameters in datasets with small sample sizes RS Terrill, Y Fong, JD Wolfe, AJ Zellmer The Auk 138 (3), ukab038, 2021 | 1 | 2021 |
| Frequent development of broadly neutralizing antibodies in early life in a large cohort of HIV-infected children A Lucier, Y Fong, SH Li, M Dennis, J Eudailey, A Nelson, K Saunders, ... bioRxiv, 2021.05. 07.443081, 2021 | | 2021 |
| Fast grid search and bootstrap‐based inference for continuous two‐phase polynomial regression models H Son, Y Fong Environmetrics 32 (3), e2664, 2021 | 11 | 2021 |
| Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials free. DV Mehrotra, HE Janes, TR Fleming, PW Annunziato, KM Neuzil, ... | | 2021 |
| Threshold-based subgroup testing in logistic regression models in two-phase sampling designs Y Huang, J Cho, Y Fong Journal of the Royal Statistical Society Series C: Applied Statistics 70 (2 …, 2021 | 6 | 2021 |
| Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials DV Mehrotra, HE Janes, TR Fleming, PW Annunziato, KM Neuzil, ... Annals of internal medicine 174 (2), 221-228, 2021 | 116 | 2021 |
| Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial (preprint) PB Gilbert, DC Montefiori, A McDermott, Y Fong, DC Benkeser, W Deng, ... | 2 | 2021 |
| Assessing durability of vaccine effect following blinded crossover in COVID-19 vaccine efficacy trials D Follmann, J Fintzi, MP Fay, HE Janes, L Baden, H El Sahly, TR Fleming, ... medRxiv, 2020 | 11 | 2020 |
| CoVPN COVID-19 Vaccine Efficacy Trial Immune Correlates SAP CB Team, J Andriesen, D Benkeser, B Borate, M Carone, L Carpp, I Diaz, ... | | 2020 |
| Rapid Collection of Human Rectal Secretions Using OriCol Devices Is Suitable for Measurement of Mucosal Ig without Blood Contamination J Czartoski, MP Lemos, Y Fong, GJ Mize, A Konchan, D Berger, J Maenza, ... The Journal of Immunology 205 (8), 2312-2320, 2020 | | 2020 |
| Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America LN Carpp, Y Fong, M Bonaparte, Z Moodie, M Juraska, Y Huang, B Price, ... PLoS One 15 (6), e0234236, 2020 | 11 | 2020 |
| Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans LP Zhao, A Fiore-Gartland, LN Carpp, KW Cohen, N Rouphael, L Fleurs, ... PloS one 15 (1), e0226803, 2020 | 19 | 2020 |
| Proportions of CD4 test results indicating advanced HIV disease remain consistently high at primary health care facilities across four high HIV burden countries K Lamp, S McGovern, Y Fong, CD Atem, JBE Nfetam, D Nzuobontane, ... PLoS One 15 (1), e0226987, 2020 | 17 | 2020 |
| Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials (preprint) D Follmann, J Fintzi, MP Fay, HE Janes, L Baden, H El Sahly, TR Fleming, ... | 3 | 2020 |
| Tutorial for the R package chngpt Y Fong | | 2019 |
| HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy PB Gilbert, Y Fong, M Juraska, LN Carpp, AS Monto, ET Martin, JG Petrie BMC infectious diseases 19, 1-12, 2019 | 36 | 2019 |
| Estimation and inference for upper hinge regression models A Elder, Y Fong Environmental and ecological statistics 26, 287-302, 2019 | 16 | 2019 |
| Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial SS Li, PB Gilbert, LN Carpp, CW Pyo, H Janes, Y Fong, X Shen, ... Journal of Virology 93 (21), 10.1128/jvi. 02041-18, 2019 | 30 | 2019 |
| Use of an indeterminate range in HIV early infant diagnosis: A systematic review and meta-analysis R Luo, D Boeras, LN Broyles, Y Fong, NY Hsiao, C Kiyaga, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 82 (3), 281-286, 2019 | 11 | 2019 |
| Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk SD Neidich, Y Fong, SS Li, DE Geraghty, BD Williamson, WC Young, ... The Journal of Clinical Investigation 129 (11), 4838-4849, 2019 | 100 | 2019 |
| Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure JA Sacks, Y Fong, MP Gonzalez, M Andreotti, S Baliga, N Garrett, ... Aids 33 (12), 1881-1889, 2019 | 28 | 2019 |
| Maximum diversity weighting for biomarkers with application in HIV‐1 vaccine studies Z He, Y Fong Statistics in medicine 38 (20), 3936-3946, 2019 | 4 | 2019 |
| Point-of-care CD4 technology invalid result rates in public health care settings across five countries K Lamp, S McGovern, Y Fong, B Abere, A Kebede, G Ayana, A Mulugeta, ... PloS one 14 (7), e0219021, 2019 | 4 | 2019 |
| Bridging efficacy of a tetravalent dengue vaccine from children/adolescents to adults in highly endemic countries based on neutralizing antibody response PB Gilbert, Y Huang, M Juraska, Z Moodie, Y Fong, A Luedtke, Y Zhuang, ... The American journal of tropical medicine and hygiene 101 (1), 164, 2019 | 14 | 2019 |
| Fc characteristics mediate selective placental transfer of IgG in HIV-infected women DR Martinez, Y Fong, SH Li, F Yang, MF Jennewein, JA Weiner, ... Cell 178 (1), 190-201. e11, 2019 | 101 | 2019 |
| Fast bootstrap confidence intervals for continuous threshold linear regression Y Fong Journal of Computational and Graphical Statistics 28 (2), 466-470, 2019 | 19 | 2019 |
| Response to Guo et al.’s Letter to the Editor Y Fong, Y Huang, MP Lemos, MJ Mcelrath Biostatistics 20 (2), 363-365, 2019 | 1 | 2019 |
| Modified wilcoxon–mann–whitney test and power against strong null Y Fong, Y Huang The American Statistician 73 (1), 43-49, 2019 | 31 | 2019 |
| Biostatistics Reviewer List 2018 D Albers, P Albert, A Alekseyenko, A Almirall, P Andersen, ... Biostatistics 20 (1), 180-181, 2019 | | 2019 |
| Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial Y Fong, ME Halloran, JK Park, F Marks, JD Clemens, DL Chao BMC infectious diseases 18, 1-8, 2018 | 12 | 2018 |
| IgG is differentially and selectively transferred across the placenta in HIV-infected women DR Martinez, Y Fong, SH Li, F Yang, M Jennewein, JA Weiner, EA Harrell, ... bioRxiv, 479121, 2018 | | 2018 |
| Higher HIV Neutralization Breadth in Young Children Than in Chronically Infected Adults SH Li, M Dennis, J Eudailey, Y Fong, J Pollara, K Saunders, C LaBranche, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 125-125, 2018 | | 2018 |
| Determinants of Transplacental Transfer of Protective Maternal IgG in HIV-infected Women DR Martinez, Y Fong, G Li, EA Harrell, M Jennewein, JA Weiner, G Alter, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 339-339, 2018 | | 2018 |
| Significant patient impact observed upon implementation of point-of-care early infant diagnosis technologies in an observational study in Malawi R Mwenda, Y Fong, T Magombo, E Saka, D Midiani, C Mwase, J Kandulu, ... Clinical Infectious Diseases 67 (5), 701-707, 2018 | 69 | 2018 |
| Rank-based two-sample tests for paired data with missing values Y Fong, Y Huang, MP Lemos, MJ Mcelrath Biostatistics 19 (3), 281-294, 2018 | 27 | 2018 |
| Modification of the association between T-cell immune responses and human immunodeficiency virus type 1 infection risk by vaccine-induced antibody responses in the HVTN 505 trial Y Fong, X Shen, VC Ashley, A Deal, KE Seaton, C Yu, SP Grant, G Ferrari, ... The Journal of infectious diseases 217 (8), 1280-1288, 2018 | 40 | 2018 |
| Rapid serological tests ineffectively screen for HIV exposure in HIV-positive infants B Urick, Y Fong, C Okiira, N Nabukeera-Barungi, D Nansera, E Ochola, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 77 (3), 331-336, 2018 | 7 | 2018 |
| A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial … SC Murphy, ER Duke, KJ Shipman, RL Jensen, Y Fong, S Ferguson, ... The Journal of infectious diseases 217 (5), 693-702, 2018 | 56 | 2018 |
| Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America Z Moodie, M Juraska, Y Huang, Y Zhuang, Y Fong, LN Carpp, SG Self, ... The Journal of infectious diseases 217 (5), 742-753, 2018 | 94 | 2018 |
| Where have all the children gone? High HIV prevalence in infants attending nutrition and inpatient entry points C Kiyaga, B Urick, Y Fong, C Okiira, N Nabukeera‐Barungi, D Nansera, ... Journal of the International AIDS Society 21 (2), e25089, 2018 | 11 | 2018 |
| Where have all the children gone? High HIV prevalence in infants attending nutrition and inpatient entry points B Urick, Y Fong, C Okiira, N Nabukeera-Barungi, D Nansera, E Ochola, ... Wiley Open Access, 2018 | | 2018 |
| Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505 Y Fong, X Shen, VC Ashley, A Deal, KE Seaton, C Yu, SP Grant, G Ferrari, ... J Infect Dis 217 (8), 1280-1288, 2018 | 6 | 2018 |
| HIV-exposed infants vaccinated with an MF59/recombinant gp120 vaccine have higher-magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine EP McGuire, Y Fong, C Toote, CK Cunningham, EJ McFarland, ... Journal of virology 92 (1), 10.1128/jvi. 01070-17, 2018 | 37 | 2018 |
| chngpt: Threshold regression model estimation and inference Y Fong, Y Huang, PB Gilbert, SR Permar BMC bioinformatics 18, 1-7, 2017 | 131 | 2017 |
| PROOF-OF-CONCEPT, RANDOMIZED STUDY IN NON-IMMUNE HEALTHY ADULT VOLUNTEERS TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC PROFILE AND PROPHYLACTIC ACTIVITY OF A SINGLE … SC Murphy, E Duke, K Shipman, R Jensen, Y Fong, E Fritzen, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 95 (5), 481-481, 2017 | | 2017 |
| Model-robust inference for continuous threshold regression models Y Fong, C Di, Y Huang, PB Gilbert Biometrics 73 (2), 452-462, 2017 | 38 | 2017 |
| CORRELATES OF RISK AND PROTECTION FOR CYD-TDV, THE FIRST LICENSED DENGUE VACCINE IN ENDEMIC COUNTRIES Z Moodie, M Juraska, Y Huang, Y Zhuang, Y Fong, SG Self, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 97 (5), 195-195, 2017 | | 2017 |
| PROPHYLACTIC ACTIVITY OF DSM265 AGAINST PRE-ERYTHROCYTIC PLASMODIUM FALCIPARUM CONTROLLED HUMAN MALARIA INFECTION BY MOSQUITO BITES AND DIRECT VENOUS INJECTION SC Murphy, E Duke, KJ Shipman, RL Jensen, Y Fong, S Ferguson, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 97 (5), 4-4, 2017 | | 2017 |
| BRIDGING EFFICACY OF THE CYD-TDV TETRAVALENT DENGUE VACCINE FROM CHILDREN/ADOLESCENTS TO ADULTS IN HIGH ENDEMIC COUNTRIES BASED ON NEUTRALIZING ANTIBODY RESPONSE PB Gilbert, Y Huang, M Juraska, Z Moodie, Y Fong, A Luedtke, Y Zhuang, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 97 (5), 248-248, 2017 | | 2017 |
| Broadly Neutralizing Antibodies Can Prevent HIV Infection in Foreskin Ex-vivo Explant Infection Models M Lemos, A Naidoo, Y Fong, L Fleming, N Mkhize, R Astronomo, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 32, 39-39, 2016 | 2 | 2016 |
| Combining biomarkers linearly and nonlinearly for classification using the area under the ROC curve Y Fong, S Yin, Y Huang Statistics in medicine 35 (21), 3792-3809, 2016 | 30 | 2016 |
| In men at risk of HIV infection, IgM, IgG1, IgG3, and IgA reach the human foreskin epidermis MP Lemos, ST Karuna, GJ Mize, Y Fong, SM Montano, C Ganoza, ... Mucosal immunology 9 (3), 798-808, 2016 | 17 | 2016 |
| Transformation model choice in nonlinear regression analysis of fluorescence-based serial dilution assays Y Fong, X Yu Statistics in biopharmaceutical research 8 (1), 1-11, 2016 | 6 | 2016 |
| Estimation and hypothesis testing for four types of change point regression models with non-thresholded covariates Y Fong, Y Huang, P Gilbert, S Permar bepress, 2016 | 1 | 2016 |
| Biostatistics-Reference of manuscripts submitted mid-2014 to mid-2015 P Albert, M Alfo, K Anstrom, A Artemious, E Bair, A Bandos, S Banerjee, ... Biostatistics 17 (1), 203-204, 2016 | | 2016 |
| Nonlinear calibration model choice between the four and five-parameter logistic models WN Cumberland, Y Fong, X Yu, O Defawe, N Frahm, S De Rosa Journal of Biopharmaceutical Statistics 25 (5), 972-983, 2015 | 45 | 2015 |
| HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition HA Prentice, GD Tomaras, DE Geraghty, R Apps, Y Fong, PK Ehrenberg, ... Science translational medicine 7 (296), 296ra112-296ra112, 2015 | 57 | 2015 |
| HIV‐1‐specific IgG antibody levels correlate with the presence of a specific HLA class II allele to impact acquisition and vaccine efficacy H Prentice, G Tomaras, D Geraghty, R Apps, Y Fong, P Ehrenberg, ... African Journal of Reproduction and Gynaecological Endoscopy 18, 2015 | | 2015 |
| Kernel-based logistic regression model for protein sequence without vectorialization Y Fong, S Datta, IS Georgiev, PD Kwong, GD Tomaras Biostatistics 16 (3), 480-492, 2015 | 7 | 2015 |
| Maternal HIV-1 envelope–specific antibody responses and reduced risk of perinatal transmission SR Permar, Y Fong, N Vandergrift, GG Fouda, P Gilbert, R Parks, ... The Journal of clinical investigation 125 (7), 2702-2706, 2015 | 83 | 2015 |
| Calibration weighted estimation of semiparametric transformation models for two‐phase sampling Y Fong, P Gilbert Statistics in medicine 34 (10), 1695-1707, 2015 | 7 | 2015 |
| Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1–serodiscordant couples EM Kahle, Partners in Prevention HSV/HIV Transmission Study Team, ... The Journal of infectious diseases 211 (9), 1451-1460, 2015 | 64 | 2015 |
| Change point testing in logistic regression models with interaction term Y Fong, C Di, S Permar Statistics in medicine 34 (9), 1483-1494, 2015 | 34 | 2015 |
Peter B. GilbertMember, Fred Hutchinson Cancer Research Center, and Research Professor, Department of Biostatistics, University of WashingtonVerified email at scharp.org
